Timing of adjuvant chemotherapy initiation and mortality among colon cancer patients at a safety-net health system

BACKGROUND: Prior studies reported survival benefits from early initiation of adjuvant chemotherapy for stage III colon cancer, but this evidence was derived from studies that may be sensitive to time-related biases. Therefore, we aimed to estimate the effect of initiating adjuvant chemotherapy ≤8 o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yan, Gehr, Aaron W., Meadows, Rachel J., Ghabach, Bassam, Neerukonda, Latha, Narra, Kalyani, Ojha, Rohit P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158363/
https://www.ncbi.nlm.nih.gov/pubmed/35641921
http://dx.doi.org/10.1186/s12885-022-09688-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158363/
https://www.ncbi.nlm.nih.gov/pubmed/35641921
http://dx.doi.org/10.1186/s12885-022-09688-w

Ejemplares similares